The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration

Recent studies have implicated the hypocretin/orexinergic system in reward-seeking behavior. Almorexant, a dual orexin/hypocretin R(1) and R(2) receptor antagonist, has proven effective in preclinical studies in promoting sleep in animal models and was in Phase III clinical trials for sleep disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Subhashini, Simms, Jeffrey A., Nielsen, Carsten K., Lieske, Steven P., Bito-Onon, Jade J., Yi, Henry, Hopf, Frederic Woodward, Bonci, Antonello, Bartlett, Selena E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448615/
https://www.ncbi.nlm.nih.gov/pubmed/23028593
http://dx.doi.org/10.1371/journal.pone.0044726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448615/
https://www.ncbi.nlm.nih.gov/pubmed/23028593
http://dx.doi.org/10.1371/journal.pone.0044726

Ejemplares similares